Woodline Partners’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,352,048
| Closed | -$27.3M | – | 852 |
|
|
2021
Q3 | $27.3M | Buy |
1,352,048
+351,723
| +35% | +$7.09M | 0.45% | 58 |
|
|
2021
Q2 | $37.3M | Sell |
1,000,325
-776,675
| -44% | -$29M | 0.7% | 35 |
|
|
2021
Q1 | $45.4M | Buy |
1,777,000
+418,204
| +31% | +$10.7M | 1.01% | 21 |
|
|
2020
Q4 | $29.9M | Buy |
1,358,796
+885,189
| +187% | +$19.5M | 0.79% | 36 |
|
|
2020
Q3 | $8.52M | Buy |
473,607
+39,996
| +9% | +$720K | 0.28% | 95 |
|
|
2020
Q2 | $11M | Sell |
433,611
-198,489
| -31% | -$5.04M | 0.44% | 69 |
|
|
2020
Q1 | $11.6M | Buy |
632,100
+260,232
| +70% | +$4.78M | 0.83% | 37 |
|
|
2019
Q4 | $8.19M | Buy |
+371,868
| New | +$8.19M | 0.33% | 74 |
|